medline.ch Respirationstrakt COPD

	Anti-type 2 monoclonal antibody therapy for eosinophilic COPD beyond triple therapy: a systematic review and meta-analysis with strict eosinophil inclusion criteria. Front Med (Lausanne) Chen J, Liang C, Wang Z. PMID: 42558912 [PubMed]
	What factors predict severity of palliative care symptoms and concerns in COPD in South Africa? A cross-sectional study. Palliat Care Soc Pract Nkhoma K, Farrant L, Hunter J, Mzimkulu O, Gwyther L, Harding R. PMID: 42558726 [PubMed]
	The interaction between illness perception and intrinsic capacity during hospital-to-home transition in older adults with COPD and diabetes: a prospective cohort study. Front Med (Lausanne) Peng X, Cheng X, Shen H, Xiao Q. PMID: 42558523 [PubMed]
	COPD and Dysphagia, a 2-Year Follow-up of the Prospective TIE-Cohort Study. COPD Gonzalez Lindh M, Bröms K, Palm A, Lisspers K, Ställberg B, Janson C, Wang J, Ellingsen J, Högman M, Malinovschi A. PMID: 42557931 [PubMed - indexed for MEDLINE]
	SGLT2i Use Reduces the Risk of COPD Exacerbations Compared With DPP4is in Patients With Diabetes and Concomitant COPD: A Systematic Review and Meta-Analysis. Am J Ther Ali D, Ahmad ZB, Waqas M, Vijay S, Ali IK, Saad M. PMID: 42557610 [PubMed - as supplied by publisher]
	Comparative effectiveness of azithromycin versus roflumilast in patients with chronic obstructive pulmonary disease: emulated target trial. BMJ Portela GT, Wang SV, Suissa S, Schneeweiss S, Feldman WB. PMID: 42556860 [PubMed - indexed for MEDLINE]
	Oxidative Stress-Driven Dysregulation of the MMP-2/TIMP-2 Axis in Chronic Obstructive Pulmonary Disease: Molecular Mechanisms, Genetic Polymorphisms, and Therapeutic Implications. Respir Med Sangwan P, Sharma JG, Habib MA, Alam MI. PMID: 42556749 [PubMed - as supplied by publisher]
	Longitudinal Outcomes and Prognostic Risk of Normalized Airflow Obstruction in a Korean General Population Cohort. Int J Chron Obstruct Pulmon Dis Kim YS, Jo YS, Rhee CK, Kim JS, Khor YH, Choi JY. PMID: 42553781 [PubMed - indexed for MEDLINE]
	Effect of evening vs. morning LAMA administration on risk of intensive care admission in COPD patients: influence of adherence post hoc analysis of the randomized controlled trial - LAMA BY NIGHT. Eur Clin Respir J Sivapalan P, Vognsen AK, Rømer V, Johansen ND, Pareek M, Modin D, Mathioudakis AG, Vestbo J, Hurst JR, Biering-Sørensen T, Jensen JS. PMID: 42553488 [PubMed]
	Efficacy of voriconazole combined with caspofungin in treating Chronic Obstructive Pulmonary Disease patients with invasive pulmonary aspergillosis: impacts on clinical outcomes, inflammatory cytokines, and immune markers. Front Immunol Zhang J, Huang Z. PMID: 42553150 [PubMed - indexed for MEDLINE]
	Accuracy, Usefulness, and Impact Variability of ChatGPT-4 for COPD Medication Management: A Modified Delphi Study. Chronic Obstr Pulm Dis Boylan PM, Lavender DL, Stone RH, Palmer R, Lamb RL, Merritt K, Caballero J. PMID: 42552543 [PubMed - as supplied by publisher]
	Blood viscosity is associated with smoking status rather than the presence of chronic obstructive pulmonary disease: findings from the Korea COPD Subgroup Study (KOCOSS). Respir Res Lee YJ, Kang HR, Kim SH, Kim HJ, Lee JS, Lee CH, Kim SK, Kim YI, Yoo KH, Kim Y. PMID: 42552534 [PubMed - indexed for MEDLINE]
	Impact of season and geography on COPDCompEx: a composite endpoint for COPD trials. Respir Med Res Spata E, Jauhiainen A, Da Silva CA. PMID: 42551404 [PubMed - as supplied by publisher]
	28-Day Mortality and Prognostic Factors in COPD Patients with Sepsis: A Retrospective Study Using eICU-CRD Database. Int J Chron Obstruct Pulmon Dis Zhu A, Sun W, Ge D, Zhang X, Zhang J, Hu M, Zhong Q, Wang Y, Liu J. PMID: 42549356 [PubMed - indexed for MEDLINE]
	Impaired Ventilatory Efficiency as a Novel Indicator of Pre-COPD: A Prospective Cohort Study. CHEST Pulm Deng Z, Wu F, Wan Q, Tang G, Zhou K, Wu X, Dai C, Lu L, Peng J, Huang S, Cai G, Wu F, Lin J, Wang X, Liang J, Wang Z, Yang H, Yang C, Huang Y, Chen R, Zhong N, Zhou Y, Ran P. PMID: 42548534 [PubMed]
	Lung Function and Safety Outcomes in Patients With Moderate-to-Severe COPD Treated With Ensifentrine: A Pooled Analysis of the ENHANCE Trials. CHEST Pulm Maselli DJ, Bon J, Rheault T, Dixon A, Reyner D, Rickard K, Lester MG. PMID: 42548501 [PubMed]
	Limitations of the AIRFLOW-3 Trial: Targeted Lung Denervation in COPD. Am J Respir Crit Care Med Zheng B. PMID: 42548115 [PubMed - as supplied by publisher]
	A Curious Case of Emphysema and Fibrosis. J Assoc Physicians India Joshi S, Gothi D. PMID: 42543961 [PubMed - indexed for MEDLINE]
	Identifying the Challenges in Self-Management and Preferences for Digital Health Technologies Use Among COPD Patients Based on the CeHRes Roadmap: A Formative Qualitative Study. Int J Chron Obstruct Pulmon Dis Tao GF, Yang S, Gao L, Huang X, Huang L. PMID: 42542781 [PubMed - indexed for MEDLINE]
	The P4COPD Study: Rationale, Goals and Study Design - Prediction, Prevention, Personalized and Precision Management of COPD in Young Adults. Open Respir Arch Agustí À, Carrizosa-Guerri X, Casanova C, Cosio B, Crispi F, Fernández-Villar A, Garcia-Aymerich J, González-de Paz L, Gonzalez JR, Iglesias A, Izquierdo JL, Marin-Oto M, Marin JM, Novoa R, Ocaña A, Pascual S, Peralta G, Perea L, Sanz-Rubio D, Sarrat-Gonzalez D, Torrent M, Vazquez M, Velasco V, Vila M, Faner R, P4COPD Study Group. PMID: 42541279 [PubMed]

Artikel 1 - 20 / 46510

Seite 1 von 2326



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung